Immunome is headquartered in Bothell, Washington.
Immunome disclosed revenue of 9M USD for 2024 and 14M USD for 2023.
Immunome has 131 employees.
Immunome is a life science company.
Immunome was founded in 2006.
18702 North Creek Parkway Suite 100,
Bothell, Washington
98011
United States,
(425) 939-7410
www.immunome.com
Immunome is a biopharmaceutical company utilizing its proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease. Immunome was founded in 2006 and is based in Bothell, Washington.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.6/yr) | # | - | - | - | 2 | 1 | - | 3 |
| vol | $6M | $6M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 3 | ||||||||
| Financial | Deals |
|---|---|
|
Stifel |
1 |
| Legal | Deals |
|---|---|
|
Mintz Levin Cohn Ferris Glovsky and Popeo |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
